SCHEMBL5480759

SCHEMBL5480759

CCCCCC(=O)S(=O)(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 4/20 0.52
CES1 P23141 4/20 0.52
AKR1B1 P15121 1/20 0.50
GPR84 Q9NQS5 7/20 0.48
PPARG P37231 7/20 0.48
PPARD Q03181 7/20 0.48
PPARA Q07869 7/20 0.48
HDAC11 Q96DB2 5/20 0.48
TSHR P16473 5/20 0.48
PTPN1 P18031 3/20 0.48
ALDH1A1 P00352 3/20 0.48
TLR2 O60603 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
FABP4 P15090 2/20 0.48
SLC22A6 Q4U2R8 1/20 0.48
SLC22A8 Q8TCC7 1/20 0.48
MEN1 O00255 1/20 0.48
ESR1 P03372 1/20 0.48
ALOX15 P16050 1/20 0.48
PDE4A P27815 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29002736 0.98 CES2 (0.54) CES2CES1GPR84PPARGPPARD
SCHEMBL9512500 0.98 CES2 (0.54) CES2CES1GPR84PPARGPPARD
SCHEMBL30818550 0.98 CES2 (0.54) CES2CES1GPR84PPARGPPARD
SCHEMBL1893982 0.98 CES2 (0.54) CES2CES1GPR84PPARGPPARD
SCHEMBL20490806 0.98 CES2 (0.54) CES2CES1GPR84PPARGPPARD
SCHEMBL23522317 0.98 CES2 (0.54) CES2CES1GPR84PPARGPPARD
SCHEMBL29266018 0.98 CES2 (0.54) CES2CES1GPR84PPARGPPARD
SCHEMBL1894203 0.98 CES2 (0.54) CES2CES1GPR84PPARGPPARD
SCHEMBL22686727 0.98 CES2 (0.54) CES2CES1GPR84PPARGPPARD
SCHEMBL28156222 0.98 CES2 (0.50) CES2CES1AKR1B1GPR84PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2582655-B1 METHOD FOR PRODUCING FILM-LIKE PRODUCT COMPRISING PI-ELECTRON CONJUGATED COMPOUND RICOH CO LTD (JP) 2022-03-30 EP disclosed
US-9293713-B2 Arylamine compound RICOH COMPANY, LTD. (JP) 2016-03-22 US disclosed
US-20130225858-A1 ARYLAMINE COMPOUND RICOH COMPANY, LTD. (JP) 2013-08-29 US disclosed
CN-103080068-A Leaving substituent-containing compound, organic semiconductor material formed therefrom, organic electronic device, organic thin-film transistor and display device using the organic semiconductor material, method for producing film-like product, pi-electron conjugated compound and method for producing the pi-electron conjugated compound RICOH CO LTD 2013-05-01 CN disclosed
EP-2582655-A1 LEAVING SUBSTITUENT-CONTAINING COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL FORMED THEREFROM, ORGANIC ELECTRONIC DEVICE, ORGANIC THIN-FILM TRANSISTOR AND DISPLAY DEVICE USING THE ORGANIC SEMICONDUCTOR MATERIAL, METHOD FOR PRODUCING FILM-LIKE PRODUCT, PI-ELECTRON CONJUGATED COMPOUND AND METHOD FOR PRODUCING THE PI-ELECTRON CONJUGATED COMPOUND Ricoh Company, Ltd. (JP) 2013-04-24 EP disclosed
US-20130095605-A1 LEAVING SUBSTITUENT-CONTAINING COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL FORMED THEREFROM, ORGANIC ELECTRONIC DEVICE, ORGANIC THIN-FILM TRANSISTOR AND DISPLAY DEVICE USING THE ORGANIC SEMICONDUCTOR MATERIAL, METHOD FOR PRODUCING FILM-LIKE PRODUCT, PI-ELECTRON CONJUGATED COMPOUND AND METHOD FOR PRODUCING THE PI ELECTRON CONJUGATED COMPOUND RICOH COMPANY, LTD. (JP) 2013-04-18 US disclosed
WO-2011158953-A1 LEAVING SUBSTITUENT-CONTAINING COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL FORMED THEREFROM, ORGANIC ELECTRONIC DEVICE, ORGANIC THIN-FILM TRANSISTOR AND DISPLAY DEVICE USING THE ORGANIC SEMICONDUCTOR MATERIAL, METHOD FOR PRODUCING FILM-LIKE PRODUCT, PI-ELECTRON CONJUGATED COMPOUND AND METHOD FOR PRODUCING THE PI-ELECTRON CONJUGATED COMPOUND RICOH COMPANY, LTD. (JP) 2011-12-22 WO disclosed
US-20070042498-A1 Method for assaying tropolone comprising complexing this molecule with cu (II) LONZA BIOLOGICS PLC. (GB) 2007-02-22 US disclosed
EP-1658490-A1 A METHOD FOR ASSAYING TROPOLONE COMPRISING COMPLEXING THIS MOLECULE WITH CU (II) Lonza Biologics plc (GB) 2006-05-24 EP disclosed
WO-2005017519-A1 A METHOD FOR ASSAYING TROPOLONE COMPRISING COMPLEXING THIS MOLECULE WITH CU (II) LONZA BIOLOGICS PLC. (GB) 2005-02-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130095605-A1 LEAVING SUBSTITUENT-CONTAINING COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL FORMED THEREFROM, ORGANIC ELECTRONIC DEVICE, ORGANIC THIN-FILM TRANSISTOR AND DISPLAY DEVICE USING THE ORGANIC SEMICONDUCTOR MATERIAL, METHOD FOR PRODUCING FILM-LIKE PRODUCT, PI-ELECTRON CONJUGATED COMPOUND AND METHOD FOR PRODUCING THE PI ELECTRON CONJUGATED COMPOUND THEM6, ORMDL3, INTS6 CES2 1574/4885CES1 3109/4885AKR1B1 4248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.